Resveratrol + pterostilbene = stronger SIRT1 activation* ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏
Resveratrol was the molecule that ignited the modern longevity movement.
| | For years, it’s been celebrated for its ability to activate sirtuin 1 (SIRT1) — the “longevity switch” that helps cells manage fuel, maintain balance, and adapt to stress.*
| | We combined resveratrol with its highly bioavailable cousin pterostilbene — creating a formula that’s stronger, steadier, and more aligned with how your biology actually works.*
| | Together, they create a fast-and-sustained activation sequence — supporting SIRT1 more effectively than resveratrol alone.*1-7,14-16
| | SIRT1 is only one part of the broader sirtuin network. The body has seven sirtuins, each with its own role. Pairing Sirtuin 1 Activator with our best-selling Sirtuin 6 Activator provides more complete support across these healthy aging pathways.*17,18
| |
SIRT1 is only one part of the broader sirtuin network. The body has seven sirtuins, each with its own role. Pairing Sirtuin 1 Activator with our best-selling Sirtuin 6 Activator provides more complete support across these healthy aging pathways.*17,18
|
|
References: - Della Vedova L et al. Pharmaceuticals (Basel). 2025;18(2):138.
- Zhou DD et al. Subcell Biochem. 2024;107:183-203.
- Li YR et al. Biofactors. 2018;44(1):69-82.
- Wood JG et al. Nature. 2004;430(7000):686-689.
- Kuršvietienė L et al. Medicina. 2016;52(3),148-155.
- Lakshminarasimhan M et al. Aging (Albany NY). 2013;5(3),151.
- Borra MT et al. J Biol Chem. 2005;280(17),17187-17195.
- Thaung Zaw JJ et al. Clin Nutr. 2021;40(3):820-829.
- Thaung Zaw JJ et al. Menopause. 2021;28(1):40-49.
- Wong RH et al. J Bone Miner Res. 2020;35(11):2121-2131.
- Thaung Zaw JJ et al. Nutrients. 2020;12(3):828.
- Chan EWC et al. J Appl Pharm Sci. 2019;9(7):124-129.
- Della Vedova L et a. Pharmaceuticals (Basel). 2025;18(2):138.
- Wang P, Sang S. Biofactors. 2018;44(1):16-25.
- Riche DM et al. J Toxicol. 2013;2013:463595.
- Kapetanovic IM et al. Cancer Chemother Pharmacol. 2011;68(3):593-601.
- López-Otín C et al. Cell. 2023;186(2):243-278.
- Jayawardena TU et al. Mar Drugs. 2022;20(12):755.
| | | | |